Skip to main content
Heart to Heart: Cardiovascular Risk in RA
Tune in as Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how

Dr. John Cush RheumNow

3 years 3 months ago
Heart to Heart: Cardiovascular Risk in RA Tune in as Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how to help mitigate CVD risk in patients with RA in the latest therapeutic update sponsored by AbbVie US Medical Affairs. https://t.co/52g6cnI5Wi https://t.co/E87OUHWFib
Comprehensive full read review of Cutaneous Lupus Erythematosus - pathogenesis, pathology and treatment options. https:/

Dr. John Cush RheumNow

3 years 3 months ago
Comprehensive full read review of Cutaneous Lupus Erythematosus - pathogenesis, pathology and treatment options. https://t.co/J7C0511kBJ https://t.co/ILhcpeT5cx
After an action packed weekend, RheumNow Live 2023 concluded on Sunday with a half-day session on systemic lupus erythematous and ankylosing spondylitis discussing many new medications that are revolutionizing rheumatology. Dr. Laurent Arnaud, a professor at Strasbourg University in France, however, took the time to review one of our oldest therapies: hydroxychloroquine.
New Therapies for PMR & GCA
Pregnancy in PsA

RheumNow Live 2023: Christina Chambers, PhD, MPH, University of California, San Diego School of Medic

Dr. John Cush RheumNow

3 years 3 months ago
Pregnancy in PsA RheumNow Live 2023: Christina Chambers, PhD, MPH, University of California, San Diego School of Medicine https://t.co/QR0Mb7F1x3 https://t.co/rj6HtoUTpE
JAK inhibitors in Psoriasis and PsA

RheumNow Live 2023: Eric Ruderman, MD, Northwestern University, Feinberg School of

Dr. John Cush RheumNow

3 years 3 months ago
JAK inhibitors in Psoriasis and PsA RheumNow Live 2023: Eric Ruderman, MD, Northwestern University, Feinberg School of Medicine https://t.co/eVwQ6ITzD7 https://t.co/GZxVx77aV1
B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's

Genetic blood tests indicated that BTK and a cytokine called

Dr. John Cush RheumNow

3 years 3 months ago
B-Cell Stimulating Factors Tied to Lymphoma in Sjogren's Genetic blood tests indicated that BTK and a cytokine called APRIL were overexpressed in patients with primary Sjögren's syndrome who subsequently developed lymphoma, French researchers reported. https://t.co/DMsjFzmjPn https://t.co/X1fg9ylo7g
Study of 481 incident RA:
- no risk of RA w/ tea, alcohol & sugar-soft drinks
- Incr RA risk seen w/ coffee [≥4 vs

Dr. John Cush RheumNow

3 years 3 months ago
Study of 481 incident RA: - no risk of RA w/ tea, alcohol & sugar-soft drinks - Incr RA risk seen w/ coffee [≥4 vs ≤1cup, HR=1.24;p=0.04] & diet drinks [HR=1.66;never-smokers] - Reduced RA risk w/ mod EtOH (ever-smokers;HR=0.63) & wine (seropos RA) https://t.co/RQFpxXUT11 https://t.co/ew2imYMLnJ
Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances

This webinar will feature highlights from these

Dr. John Cush RheumNow

3 years 3 months ago
Tuesday Night Rheumatology: POD 3: Vasculitis: Evolution and Advances This webinar will feature highlights from these lectures followed by live audience Q & A: -New Therapies for PMR & GCA -Assessment of GCA and PMR -GPA Treatment Choices https://t.co/PRj6QQnxIS https://t.co/Y4aCyTrg0Z
One in Ten has Autoimmune Disease

A UK population-based study suggests that autoimmune diseases affect approximately o

Dr. John Cush RheumNow

3 years 3 months ago
One in Ten has Autoimmune Disease A UK population-based study suggests that autoimmune diseases affect approximately one in ten individuals. https://t.co/a2VbAO0Fc6 https://t.co/69Yl9OTtKY
REMIT-UC: Tofacitinib study 334 w/ Ulcerative Colitis:Clinical remission in 35%, Endoscopic remission in ~24%; & low

Dr. John Cush RheumNow

3 years 3 months ago
REMIT-UC: Tofacitinib study 334 w/ Ulcerative Colitis:Clinical remission in 35%, Endoscopic remission in ~24%; & low risk (per/100PY) of serious infections (2.1), H zoster (0.5), & VTE (1.1). Loss of response in 45%, but recaptured 55% w/ dose escalation https://t.co/KgSrKBbv40 https://t.co/M74l4tOA3U
Heart to Heart: Cardiovascular Risk in RA
Tune in to hear experts discuss cardiovascular risk assessment, patient educat

Dr. John Cush RheumNow

3 years 3 months ago
Heart to Heart: Cardiovascular Risk in RA Tune in to hear experts discuss cardiovascular risk assessment, patient education, and the importance of disease control in the latest therapeutic update sponsored by AbbVie US Medical Affairs. https://t.co/Tz8VBiXhwt https://t.co/EQ0dRmM27r
RT @UMichMedSchool: When Hannah Glick receives her M.D. this week, she will join her mother, Dr. Rachel Glick, and grand

University of Michigan Medical School UMichMedSchool

3 years 3 months ago
When Hannah Glick receives her M.D. this week, she will join her mother, Dr. Rachel Glick, and grandmother, Dr. Marilyn Heins, as the only family in the U.S. with three generations of women doctors that are living, according to @AAMCtoday. https://t.co/AzRw2I4CU8 #GoBlueMed https://t.co/0tgMwVLwxF
×